Current capabilities and capacity of Ebola treatment centers in the United States

Jocelyn J. Herstein, Paul D. Biddinger, Colleen S. Kraft, Lisa Saiman, Shawn G. Gibbs, Aurora B. Le, Philip W. Smith, Angela L Hewlett, John-Martin J Lowe

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

objective. To describe current Ebola treatment center (ETC) locations, their capacity to care for Ebola virus disease patients, and infection control infrastructure features. design. A 19-question survey was distributed electronically in April 2015. Responses were collected via email by June 2015 and analyzed in an electronic spreadsheet. setting. The survey was sent to and completed by site representatives of each ETC. participants. The survey was sent to all 55 ETCs; 47 (85%) responded. results. Of the 47 responding ETCs, there are 84 isolation beds available for adults and 91 for children; of these pediatric beds, 35 (38%) are in children’s hospitals. In total, the simultaneous capacity of the 47 reporting ETCs is 121 beds. On the basis of the current US census, there are 0.38 beds per million population. Most ETCs have negative pressure isolation rooms, anterooms, and a process for category A waste sterilization, although only 11 facilities (23%) have the capability to sterilize infectious waste on site. conclusions. Facilities developed ETCs on the basis of Centers for Disease Control and Prevention guidance, but specific capabilities are not mandated at this present time. Owing to the complex and costly nature of Ebola virus disease treatment and variability in capabilities from facility to facility, in conjunction with the lack of regulations, nationwide capacity in specialized facilities is limited. Further assessments should determine whether ETCs can adapt to safely manage other highly infectious disease threats.

Original languageEnglish (US)
Pages (from-to)313-318
Number of pages6
JournalInfection Control and Hospital Epidemiology
Volume37
Issue number3
DOIs
StatePublished - Dec 7 2015

Fingerprint

Ebola Hemorrhagic Fever
Censuses
Centers for Disease Control and Prevention (U.S.)
Infection Control
Communicable Diseases
Therapeutics
Pediatrics
Pressure
Population
Surveys and Questionnaires

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Current capabilities and capacity of Ebola treatment centers in the United States. / Herstein, Jocelyn J.; Biddinger, Paul D.; Kraft, Colleen S.; Saiman, Lisa; Gibbs, Shawn G.; Le, Aurora B.; Smith, Philip W.; Hewlett, Angela L; Lowe, John-Martin J.

In: Infection Control and Hospital Epidemiology, Vol. 37, No. 3, 07.12.2015, p. 313-318.

Research output: Contribution to journalArticle

Herstein, Jocelyn J. ; Biddinger, Paul D. ; Kraft, Colleen S. ; Saiman, Lisa ; Gibbs, Shawn G. ; Le, Aurora B. ; Smith, Philip W. ; Hewlett, Angela L ; Lowe, John-Martin J. / Current capabilities and capacity of Ebola treatment centers in the United States. In: Infection Control and Hospital Epidemiology. 2015 ; Vol. 37, No. 3. pp. 313-318.
@article{d1258e76b8464296a248e79fe5324c02,
title = "Current capabilities and capacity of Ebola treatment centers in the United States",
abstract = "objective. To describe current Ebola treatment center (ETC) locations, their capacity to care for Ebola virus disease patients, and infection control infrastructure features. design. A 19-question survey was distributed electronically in April 2015. Responses were collected via email by June 2015 and analyzed in an electronic spreadsheet. setting. The survey was sent to and completed by site representatives of each ETC. participants. The survey was sent to all 55 ETCs; 47 (85{\%}) responded. results. Of the 47 responding ETCs, there are 84 isolation beds available for adults and 91 for children; of these pediatric beds, 35 (38{\%}) are in children’s hospitals. In total, the simultaneous capacity of the 47 reporting ETCs is 121 beds. On the basis of the current US census, there are 0.38 beds per million population. Most ETCs have negative pressure isolation rooms, anterooms, and a process for category A waste sterilization, although only 11 facilities (23{\%}) have the capability to sterilize infectious waste on site. conclusions. Facilities developed ETCs on the basis of Centers for Disease Control and Prevention guidance, but specific capabilities are not mandated at this present time. Owing to the complex and costly nature of Ebola virus disease treatment and variability in capabilities from facility to facility, in conjunction with the lack of regulations, nationwide capacity in specialized facilities is limited. Further assessments should determine whether ETCs can adapt to safely manage other highly infectious disease threats.",
author = "Herstein, {Jocelyn J.} and Biddinger, {Paul D.} and Kraft, {Colleen S.} and Lisa Saiman and Gibbs, {Shawn G.} and Le, {Aurora B.} and Smith, {Philip W.} and Hewlett, {Angela L} and Lowe, {John-Martin J}",
year = "2015",
month = "12",
day = "7",
doi = "10.1017/ice.2015.300",
language = "English (US)",
volume = "37",
pages = "313--318",
journal = "Infection Control and Hospital Epidemiology",
issn = "0899-823X",
publisher = "University of Chicago Press",
number = "3",

}

TY - JOUR

T1 - Current capabilities and capacity of Ebola treatment centers in the United States

AU - Herstein, Jocelyn J.

AU - Biddinger, Paul D.

AU - Kraft, Colleen S.

AU - Saiman, Lisa

AU - Gibbs, Shawn G.

AU - Le, Aurora B.

AU - Smith, Philip W.

AU - Hewlett, Angela L

AU - Lowe, John-Martin J

PY - 2015/12/7

Y1 - 2015/12/7

N2 - objective. To describe current Ebola treatment center (ETC) locations, their capacity to care for Ebola virus disease patients, and infection control infrastructure features. design. A 19-question survey was distributed electronically in April 2015. Responses were collected via email by June 2015 and analyzed in an electronic spreadsheet. setting. The survey was sent to and completed by site representatives of each ETC. participants. The survey was sent to all 55 ETCs; 47 (85%) responded. results. Of the 47 responding ETCs, there are 84 isolation beds available for adults and 91 for children; of these pediatric beds, 35 (38%) are in children’s hospitals. In total, the simultaneous capacity of the 47 reporting ETCs is 121 beds. On the basis of the current US census, there are 0.38 beds per million population. Most ETCs have negative pressure isolation rooms, anterooms, and a process for category A waste sterilization, although only 11 facilities (23%) have the capability to sterilize infectious waste on site. conclusions. Facilities developed ETCs on the basis of Centers for Disease Control and Prevention guidance, but specific capabilities are not mandated at this present time. Owing to the complex and costly nature of Ebola virus disease treatment and variability in capabilities from facility to facility, in conjunction with the lack of regulations, nationwide capacity in specialized facilities is limited. Further assessments should determine whether ETCs can adapt to safely manage other highly infectious disease threats.

AB - objective. To describe current Ebola treatment center (ETC) locations, their capacity to care for Ebola virus disease patients, and infection control infrastructure features. design. A 19-question survey was distributed electronically in April 2015. Responses were collected via email by June 2015 and analyzed in an electronic spreadsheet. setting. The survey was sent to and completed by site representatives of each ETC. participants. The survey was sent to all 55 ETCs; 47 (85%) responded. results. Of the 47 responding ETCs, there are 84 isolation beds available for adults and 91 for children; of these pediatric beds, 35 (38%) are in children’s hospitals. In total, the simultaneous capacity of the 47 reporting ETCs is 121 beds. On the basis of the current US census, there are 0.38 beds per million population. Most ETCs have negative pressure isolation rooms, anterooms, and a process for category A waste sterilization, although only 11 facilities (23%) have the capability to sterilize infectious waste on site. conclusions. Facilities developed ETCs on the basis of Centers for Disease Control and Prevention guidance, but specific capabilities are not mandated at this present time. Owing to the complex and costly nature of Ebola virus disease treatment and variability in capabilities from facility to facility, in conjunction with the lack of regulations, nationwide capacity in specialized facilities is limited. Further assessments should determine whether ETCs can adapt to safely manage other highly infectious disease threats.

UR - http://www.scopus.com/inward/record.url?scp=84959196792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959196792&partnerID=8YFLogxK

U2 - 10.1017/ice.2015.300

DO - 10.1017/ice.2015.300

M3 - Article

C2 - 26641267

AN - SCOPUS:84959196792

VL - 37

SP - 313

EP - 318

JO - Infection Control and Hospital Epidemiology

JF - Infection Control and Hospital Epidemiology

SN - 0899-823X

IS - 3

ER -